脏的参与与患有血管免疫发育性T细胞淋巴瘤的患者的生存时间缩短有关

Yingdan Huang1, Ruolan Zeng2, Chang Xue1

  • 1Department of Lymphoma Medicine, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, China.

概括

脏干扰是血管免疫细胞T细胞淋巴瘤 (AITL) 预后不佳的重要预测因素. 这一发现有助于识别高风险的AITL患者,以定制治疗策略.